FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156354702> ?p ?o ?g. }

• W2156354702 endingPage "266" @default.
• W2156354702 startingPage "257" @default.
• W2156354702 abstract "Inhibition of the epidermal growth factor receptor (EGFR) is a fastly developing field in preclinical and clinical cancer research. This review presents the current status of knowledge and discusses radiobiological mechanisms which may underly the efficacy of EGFR inhibitors combined with irradiation.Preclinical and clinical results on combined targeting of the EGFR and irradiation from the literature and from this laboratory are reviewed. Focus is given to the radiobiological rationale of this approach and to endpoints of experimental radiotherapy.Overexpression of the EGFR is associated with decreased local tumour control after radiotherapy, especially when the overall treatment time is long. Inhibition of the EGFR either alone or in combination with irradiation decreases the growth rate of tumours expressing this receptor. Preclinical data provide proof-of-principle that local tumour control may be improved by combining irradiation with C225 mAb. In a randomised phase III clinical trial, simultaneous irradiation and treatment with the EGFR antibody Cetuximab (Erbitux; C225) in head and neck cancer patients resulted in significantly improved locoregional tumour control and survival compared to curative irradiation alone. Acute skin reactions increased in the experimental arm. The underlying mechanisms of enhanced radiation effects of combined EGFR inhibition with irradiation and of the partly conflicting results in different studies are poorly understood. There is increasing evidence, that important intertumoral heterogeneity in the response to EGFR inhibition alone and combined with irradiation exists, which appears to be at least partly dependent on specific mutations of the receptor as well as of molecules that are involved in the intracellular signal transduction pathway.Further investigations at all levels of the translational research chain exploring the mechanisms of EGFR inhibition in the context of radiotherapy are needed to fully exploit the potential of such combinations and to develop predictive tests that direct their use." @default.
• W2156354702 created "2016-06-24" @default.
• W2156354702 creator A5028492548 @default.
• W2156354702 creator A5083101824 @default.
• W2156354702 date "2004-09-01" @default.
• W2156354702 modified "2023-09-25" @default.
• W2156354702 title "Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results" @default.
• W2156354702 cites W1262734359 @default.
• W2156354702 cites W1977340600 @default.
• W2156354702 cites W1992964845 @default.
• W2156354702 cites W1996999925 @default.
• W2156354702 cites W1997159039 @default.
• W2156354702 cites W1998962333 @default.
• W2156354702 cites W2001598945 @default.
• W2156354702 cites W2007535198 @default.
• W2156354702 cites W2008575388 @default.
• W2156354702 cites W2008803651 @default.
• W2156354702 cites W2014134684 @default.
• W2156354702 cites W2014836749 @default.
• W2156354702 cites W2022897735 @default.
• W2156354702 cites W2025313715 @default.
• W2156354702 cites W2027208483 @default.
• W2156354702 cites W2033558612 @default.
• W2156354702 cites W2034309045 @default.
• W2156354702 cites W2036926586 @default.
• W2156354702 cites W2041808732 @default.
• W2156354702 cites W2043696829 @default.
• W2156354702 cites W2046234733 @default.
• W2156354702 cites W2047353118 @default.
• W2156354702 cites W2048454485 @default.
• W2156354702 cites W2056743298 @default.
• W2156354702 cites W2057458801 @default.
• W2156354702 cites W2074094034 @default.
• W2156354702 cites W2075816930 @default.
• W2156354702 cites W2087625045 @default.
• W2156354702 cites W2087677447 @default.
• W2156354702 cites W2090871977 @default.
• W2156354702 cites W2094337557 @default.
• W2156354702 cites W2099396077 @default.
• W2156354702 cites W2110835998 @default.
• W2156354702 cites W2111693820 @default.
• W2156354702 cites W2112266802 @default.
• W2156354702 cites W2120784306 @default.
• W2156354702 cites W2122314043 @default.
• W2156354702 cites W2127101185 @default.
• W2156354702 cites W2131361386 @default.
• W2156354702 cites W2153241046 @default.
• W2156354702 cites W21553284 @default.
• W2156354702 cites W2161821474 @default.
• W2156354702 cites W2167531081 @default.
• W2156354702 cites W2167698780 @default.
• W2156354702 cites W2169434055 @default.
• W2156354702 cites W4234782282 @default.
• W2156354702 cites W4236628553 @default.
• W2156354702 cites W4240138574 @default.
• W2156354702 cites W4243015778 @default.
• W2156354702 cites W4299808459 @default.
• W2156354702 doi "https://doi.org/10.1016/j.radonc.2004.07.007" @default.
• W2156354702 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15450723" @default.
• W2156354702 hasPublicationYear "2004" @default.
• W2156354702 type Work @default.
• W2156354702 sameAs 2156354702 @default.
• W2156354702 citedByCount "168" @default.
• W2156354702 countsByYear W21563547022012 @default.
• W2156354702 countsByYear W21563547022013 @default.
• W2156354702 countsByYear W21563547022014 @default.
• W2156354702 countsByYear W21563547022015 @default.
• W2156354702 countsByYear W21563547022016 @default.
• W2156354702 countsByYear W21563547022017 @default.
• W2156354702 countsByYear W21563547022018 @default.
• W2156354702 countsByYear W21563547022019 @default.
• W2156354702 countsByYear W21563547022020 @default.
• W2156354702 countsByYear W21563547022021 @default.
• W2156354702 countsByYear W21563547022022 @default.
• W2156354702 crossrefType "journal-article" @default.
• W2156354702 hasAuthorship W2156354702A5028492548 @default.
• W2156354702 hasAuthorship W2156354702A5083101824 @default.
• W2156354702 hasConcept C121608353 @default.
• W2156354702 hasConcept C126322002 @default.
• W2156354702 hasConcept C143998085 @default.
• W2156354702 hasConcept C170493617 @default.
• W2156354702 hasConcept C2777506169 @default.
• W2156354702 hasConcept C2779438470 @default.
• W2156354702 hasConcept C2779998722 @default.
• W2156354702 hasConcept C502942594 @default.
• W2156354702 hasConcept C509974204 @default.
• W2156354702 hasConcept C526805850 @default.
• W2156354702 hasConcept C535046627 @default.
• W2156354702 hasConcept C71924100 @default.
• W2156354702 hasConceptScore W2156354702C121608353 @default.
• W2156354702 hasConceptScore W2156354702C126322002 @default.
• W2156354702 hasConceptScore W2156354702C143998085 @default.
• W2156354702 hasConceptScore W2156354702C170493617 @default.
• W2156354702 hasConceptScore W2156354702C2777506169 @default.
• W2156354702 hasConceptScore W2156354702C2779438470 @default.
• W2156354702 hasConceptScore W2156354702C2779998722 @default.
• W2156354702 hasConceptScore W2156354702C502942594 @default.
• W2156354702 hasConceptScore W2156354702C509974204 @default.

• next